Superimposition evaluation of ecdysteroid agonist chemotypes through multidimensional QSAR

Journal of Computer-Aided Molecular Design

Volumn 17, Issue 2-4, 2003, Pages 135-153

  Hormann, Robert E ^a   Dinan, Laurence ^b   Whiting, Pensri ^b  

^a LLC   (United States)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

4D QSAR; CoMFA; Diacylhydrazines; Ecdysteroid receptor; Ecdysteroids; QSAR

Indexed keywords

CELL CULTURE; COMPUTATIONAL CHEMISTRY; MOLECULAR GRAPHICS; VIRTUAL ADDRESSES;

4D-QSAR; CHEMOTYPES; COMFA; DIACYLHYDRAZINES; DROSOPHILLA MELANOGASTER; ECDYSTEROID RECEPTOR; ECDYSTEROIDS; QSAR; TRAINING SETS;

GENE EXPRESSION;

DIACYLHYDRAZINE; ECDYSTEROID; ESTRADIOL; HORMONE RECEPTOR STIMULATING AGENT; STEROID RECEPTOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ALGORITHM; ANALYTIC METHOD; ARTICLE; CONFORMATION; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; GENE EXPRESSION SYSTEM; HYDROGEN BOND; INTERMETHOD COMPARISON; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING; SEQUENCE HOMOLOGY; STATISTICAL ANALYSIS;

EID: 0042856644     PISSN: 0920654X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025365722403     Document Type: Article

References (60)

1. Wing, K.D., Science 241 (1988) 467.
2. Wing, K.D., Slawecki, R. A. and Carlson, G. R., Science 241 (1988) 470.
3. Dhadialla, T. S., Carlson, G. R. and Le, D. P., Annual Reviews in Entomology 43 (1998) 545.
4. Laudet, V. and Gronemeyer, H., The Nuclear Receptor Facts-Book, Academic Press, London, 2002.
5. Lezzi, M., Bergman, T., Mouillet, J.-F. and Henrich, V. C., Arch. Insect Biochem. Physiol. 41 (1999) 99.
6. Koolman, J. (Ed.), Ecdysone: from chemistry to mode of action, Thieme, Stuttgart, 1989.
7. Allgood, V.E. and Eastman, E.M., Curr. Opin. Biotechnol. 8 (1997) 474.
8. Palli, S. R. and Kapitskaya, M.Z., International patent application, WO-2002/066614, 2002, Rohm and Haas Co.
9. Palli, S.R. and Kapitskaya, M.Z., International patent application, WO-2002/066613, 2002, Rohm and Haas Co.
10. Evans, R.M., No, D. and Saez, E., US patent application, US 2002/0177564 A1, 2002, The Salk Institute for Biological Studies.
11. Gage, F. H. and Suhr, S. T., International patent application, WO-99/02683, 1999, The Salk Institute for Biological Studies.
12. Hsu, A.C.-T., Fujimoto, T.T. and Dhadialla, T.S., ACS Symposium Series 658, American Chemical Society, Washington, D.C., 1997, 206-219.
13. Lüers, G.H., Jess, N. and Franz T., Eur. J. Cell Biol. 79 (2000) 653.
14. No, D., Yao, T.-P. and Evans, R.M., Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3346.
15. Saez, E., Nelson, M.C., Eshelman, B., Banayo, E., Koder, A., Cho, G.J. and Evans, R.M., Proc. Nat. Acad. Sci. 97 (2000) 14512.
16. Carlson, G.R., Cress, D.E., Dhadialla, T.S., Hormann, R.E. and Le, D.P., US Patent 6,258,603, 2001, Rohm and Haas Co.
17. Graham, L.D., Expert Opinion on Biological Therapy, 2, 5 (2002) 525.
18. McNeish, I. and Seckl, M.J., In Brooks, G. (Ed.), Gene Therapy, Pharmaceutical Press, London, 2002, 87-134.
19. Hsich, G., Sena-Esteves, M. and Breakefield, X.O., Human Gene Therapy, 13, 5 (2002) 579.
20. Vara, D.J., Movassagh, M. and Brooks, G., In Brooks, G., (Ed.), Gene Therapy, Pharmaceutical Press, London, 2002, 135-188.
21. O'Dea, S. and Harrison, D.J., Current Gene Therapy, 2, 2 (2002) 173.
22. Frater, J.A., Fidler, S.J. and McClure, M.O., In Brooks, G., (Ed.), Gene Therapy, Pharmaceutical Press, London, 2002, 189-213.
23. Balicki, D. and Beutler, E., Medicine, 81, 1 (2002) 69.
24. Kaplan, J., Gene Therapy, 9, 11 (2002) 658.
25. Bestor, T.H., J. Clin. Invest. 105 (2000) 409.
26. Gee, A.P., Journal of Cellular Biochemistry, Suppl. 38 (2002) 104.
27. Shiau, A.K., Barstad, D., Loria, P.M., Cheng, L., Kushner, P.J., Agard, D.A. and Greene, G.L., Cell 95 (1998) 927.
28. Nakagawa, Y., Shimizu, B.-i., Oikawa, N., Akamatsu, M., Nishimura, K., Kurihara, N., Ueno, T. and Fujita, T., In Hansch, C. and Fujita, T., (Eds.), Classical and Three-Dimensional QSAR in Agrochemistry, American Chemical Society, Washington, D.C., 1995, 288-301.
29. Shimizu, B.-i., Nakagawa, Y., Hattori, K., Nishimura, K., Kurihara, N. and Ueno, T., Steroids 62 (1997) 638.
30. Nakagawa Y., Hattori K., Shimizu B.-i., Akamatsu M., Miyagawa H. and Ueno T., Pesticide Science 53 (1998) 267.
31. Wurtz, J.-M., Guillot, B., Fagart, J., Moras, D., Tietjen, K. and Schindler, M., Protein Science 9 (2000) 1073.
32. Qian, X., Journal of Agricultural and Food Chemistry 44 (1996) 1538.
33. Mohammed-Ali, A.K., Chan, T.-H., Thomas, AW., Strunz, G.M. and Jewett, B., Canadian Journal of Chemistry 73 (1995) 550.
34. Clément, C.Y., Bradbrook, D.A., Lafont, R. and Dinan, L., Insect Biochem. Molec. Biol. 23 (1993) 187.
35. Dinan, L., Hormann, R.E. and Fujimoto, T., J. of Comp.-Aided Mol. Des. 13 (1999) 185.
36. Lafont, R.D. and Wilson, I.D. (Eds.), The Ecdysone Handbook, 2nd ed., The Chromatographic Society, Nottingham, 1996.
37. Structures 15, 22, 30, 60, and 63 in reference 35.
38. Manuscript in preparation.
39. Sybyl 6.7, Tripos Associates, 1699 South Hanley Road, St. Louis, MO 63144.
40. Huber, R. and Hoppe, W., Chem. Ber. 98 (1965) 2403.
41. Chan, T.H., Ali, A., Britten, J.F., Thomas, AW., Strunz, G.M., Salonius, A., Canadian Journal of Chemistry 68 (1990) 1178.
42. Clark, M., Cramer III, R.D. and van Opdenbosch, N.J., Journal of Computational Chemistry 10 (1989) 982.
43. Jones, G., Willett, P. and Glen, R.C., J. Comput.-Aided Mol. Design 9 (1995) 532.
44. Kubinyi, H., (Ed.), 3D QSAR in Drug Design: Theory, Methods and Applications, Vol 1, Kluwer Academic Publishers, Dordrecht, 1998.
45. Kubinyi, H., Folkers, G. and Martin, Y.C., (Eds.), 3D QSAR in Drug Design: Recent Adavances, Vol 3, Kluwer Academic Publishers, Dordrecht, 1998.
46. Hopfinger, A.J., Wang, S., Tokarski, J.S., Jin, B., Albuquerque, M., Madhav, P.J. and Duraiswami, C., J. Am. Chem. Soc. 119 (1997) 10509.
47. Hopfinger, A. and Tokarski, J., In Charifson, P.S., (Ed.), Practical Application of Computer- Aided Drug Design, Dekker, New York, 1997, p. 105.
48. Hopfinger, A.J. and Duca, J.S., Curr. Opin. Biotech. 11 (2000) 97.
49. Ravi, M., Hopfinger, A.J., Hormann, R.E. and Dinan, L., Journal of Information and Computer Sciences, 41, 6 (2001) 1587.
50. 4D-QSAR 3.0, The Chem21 Group, 1780 Wilson Drive, Lake Forest, IL, 60045.
51. Hansch, C. and Leo, A., Exploring QSAR, American Chemical Society, Washington, D.C., 1995.
52. Golbraikh, A. and Tropsha, A., Journal of Molecular Graphics and Modeling 20 (2002) 269.
53. R.E. Hormann, unpublished.
54. Chavravorty, S. and Reynolds, C., personal communication.
55. Reynolds, C.H. and Hormann, R.E., J. Am. Chem. Soc., 118, 39 (1996) 9395.
56. 2.
57. Klebe G., Abraham U. and Mietzner T., J. Med. Chem. 37 (1994) 4130-4146.
58. Klebe, G., In Kubinyi, H., Folkers, G., Martin, Y.C., (Eds.), 3D QSAR in Drug Design: Recent Advances, Vol. 3, Kluwer Academic Publishers, Dordrecht, 1998, 87-104.
59. Fortuitously, this conformation is related to one proposed by investigators at Bayer AG and IGBMC, and developed through EcR homology modeling. Klaus Tietjen, personal communication, Rohm and Haas 1998.
60. Nakagawa Y., Hattori K., Shimizu B.-I., Akamatsu, M., Miyagawa, H. and Ueno T., Pesticide Science 53 (1998) 267.